The Mario Negri Institute for Pharmacological Research, a PERMIT consortium member, has published an article in its online magazine on personalised medicine. It provides an overview, in lay terms of the basis of personalised medicine, its fields of application, its current challenges, its costs and the ethical questions it raises. The article also highlights European initiatives on personalised medicine such as the ICPerMed and the PERMIT Project and provides outlooks on the future of personalised medicine. Read the full article here (article in Italian).
@ECRIN_ERIC
Oct 28th
Don't miss this upcoming webinar from EulacPermed.
In-silico models and personalised medicine.
?Nov 25, 15:00CET
Register todaecrin.org/event/webinar-…Y9C
FYI @ t#PERMITprojectect community https://t.co/KjVk8OEum3
@ECRIN_ERIC
Sep 24th
What is happening in the #PERMITproject? This month marked the final #PERMITproject workshop to define recommendations for robust and reproducible preclinical research in #personalisedmedicine.
Learn more about the 5 themes to guide these recommendations
permit-eu.org/article/recomm… https://t.co/KdkFKmgwJZ
@ECRIN_ERIC
Sep 23rd
Thank you ERIC_forum for highlighting the work carried out on the ECRIN coordinated project pedcrin and #PERMITProject. We are lucky to have amazing partners in these projects that help us move them forward successfully. twitter.com/ERIC_forum/sta…